Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

proverbialwisdom

proverbialwisdom's Journal
proverbialwisdom's Journal
July 15, 2016

Yesterday, Reverend Jesse Jackson urged President Obama to veto the GMO labeling bill.

Today Reverend Jesse Jackson urged President Obama to veto the GMO labeling bill that is currently before the House, should it reach his desk. In a letter sent directly to the president the renowned civil rights activist called attention to the “serious inequities (in the) GMO labeling legislation.” In the letter Jackson points out the discriminatory nature of such a labeling system; “100,000,000 Americans, most of them poor, people of color and elderly either do not own a smart phone or an iPhone to scan the QR code or live in an area of poor internet connectivity.”

LETTER: http://www.centerforfoodsafety.org/files/jesse-jackson-letter-to-obama_12626.pdf

Info from Center for Food Safety email.

July 15, 2016

Russian Billionaires in U.S. Health Push With D.C. Insiders

Source: Irina Reznik and Alex Sazonov, Washington Post

Jul 15, 2016, 7:06 am ET

(Bloomberg) -- Mikhail Fridman cashed out of his Russian oil venture near the top of the market and moved to London to build an empire in calmer climes. Then Brexit struck, reinforcing his determination to keep heading west.

With Britain’s decision to leave the European Union and sanctions over Ukraine muddying the investment waters from Moscow to Glasgow, Fridman and his three fellow Alfa Group billionaires are looking across the Atlantic and see a clear stream of profit in ever-higher spending on health care. With two Washington insiders in tow to help navigate the terrain, the Russians are preparing to invest as much as $3 billion in the industry over three years, starting in the U.S., where it accounts for almost a fifth of the economy.

“There are signals of a major tectonic shift in economic development happening before our eyes,” Fridman said in an interview in London.

Flush with almost $14 billion from the sale in 2013 of TNK-BP to state-owned Rosneft PJSC, Fridman and his partners created Luxembourg-based LetterOne to acquire western projects to balance their holdings back home. After buying North Sea energy assets, U.K. student housing and a slice of Uber Technologies Inc., they have about half left to deploy.

The skills and tactics that allowed Fridman to flourish in post-Soviet Russia won’t necessarily translate into success in the U.S., particularly with relations at a post-Cold War low. So he and his partners, who are both decried and admired for their mastery of what is known as administrative resources -- the aggressive use of connections, courts and cops to achieve commercial aims -- have brought on board people with ties to both major candidates for president.

Read more: http://washpost.bloomberg.com/Story?docId=1376-OA8XN66JIJUT01-4TSPURT7UORR6BQ31V7I6NQG0J



via Bloomberg TV side screen headlne: "With Britain's decision to leave the European Union and sanctions over Ukraine muddying the investment waters from Moscow to Glasgow, Fridman and his three fellow Alfa Group billionaires are looking across the Atlantic and see a clear stream of profit in ever-higher spending on health care."
July 14, 2016

“Human Genome Project-Write” Unveiled

http://www.the-scientist.com/?articles.view/articleNo/46237/title/-Human-Genome-Project-Write--Unveiled/

“Human Genome Project-Write” Unveiled

A proposal to synthesize entire genomes—the subject of a controversial, invitation-only meeting at Harvard last month—is formally presented in Science.

By Jef Akst | June 2, 2016


A team led by New York University’s Jef Boeke, Harvard’s George Church, and Andrew Hessel of the California-based commercial design studio Autodesk Research has published its proposal to synthesize entire genomes from scratch, including those of humans. Called the “Human Genome Project-Write” (the authors refer to the original HGP as Human Genome Project-Read), the initiative could take 10 years and a minimum of $100 million just to get started, the researchers wrote today (June 2) in Science.

“It’s essentially a call to action,” Hessel told BuzzFeed News. “We are suggesting it’s time to consider a new genome project standing on the foundations of the Human Genome Project.”

An underlying goal of the proposed project is to develop technologies to more efficiently and more cheaply write DNA. “Tangible products may be slow to follow at first, but writing DNA more cheaply and at large scale will make researchers more efficient and comprehensive in their work, leading to practically unlimited potential for indirect products,” Danielle Tullman-Ercek, a biochemical engineer at the University of California, Berkeley, told Nature.

But the proposal was not universally praised. “My first thought was ‘so what,’” Martin Fussenegger, a synthetic biologist at the Swiss Federal Institute of Technology in Zurich, told Nature. “I personally think this will happen naturally. It’s just a matter of price at the end.”

Others are still upset about the discussion that took place at a closed-door meeting last month at Harvard. Synthetic biologist Drew Endy of Stanford University and religious scholar Laurie Zoloth of Northwestern University in Evanston, Illinois, question the scientific value of the plan. “Boeke et al.’s current proposal should be broadly rejected and not now pursued,” Endy told BuzzFeed News in an email.


MOONSHOT SEGMENT (Andrew Hessel, distinguished research scientist at Autodesk, and Ethan Kurzweil, a Bessemer Venture Partners partner): http://www.bloomberg.com/news/videos/2016-07-14/full-show-bloomberg-west-07-13

https://mobile.twitter.com/emilychangtv/status/753355474058170368

Emily Chang
@emilychangtv


Our new Series A segment live now! Today's topic: Moonshots with @ethankurz @andrewhessel bloomberg.com/live
3:28 PM - 13 Jul 2016
July 11, 2016

Carl Sagan? Check out Jennifer Margulis.

https://en.wikipedia.org/wiki/Carl_Sagan

SAGAN'S 1ST SPOUSE: https://en.wikipedia.org/wiki/Lynn_Margulis

Throughout her career, Margulis’ work could arouse intense objection (one grant application elicited the response, "Your research is crap, do not bother to apply again{4}), and her formative paper, "On the Origin of Mitosing Cells," appeared in 1967 after being rejected by about fifteen journals.

<>

In 1995, English evolutionary biologist Richard Dawkins had this to say about Lynn Margulis and her work:

"I greatly admire Lynn Margulis's sheer courage and stamina in sticking by the endosymbiosis theory, and carrying it through from being an unorthodoxy to an orthodoxy. I'm referring to the theory that the eukaryotic cell is a symbiotic union of primitive prokaryotic cells. This is one of the great achievements of twentieth-century evolutionary biology, and I greatly admire her for it."{24}


4. Sagan, Dorion, ed. (2012). Lynn Margulis: The Life and Legacy of a Scientific Rebel. White River Junction: Chelsea Green. ISBN 978-1-603-58446-3.

24. Margulis, Lynn, Gaia Is a Tough Bitch. Chapter 7 in The Third Culture: Beyond the Scientific Revolution by John Brockman (Simon & Schuster, 1995)

DAUGHTER: http://jennifermargulis.net/
http://jennifermargulis.net/about/
https://www.amazon.com/Vaccine-Friendly-Plan-Effective-Health-Pregnancy/dp/1101884231/178-0574487-0383232

July 6, 2016

Here's the NIH.GOV press release, also in post #4, but I did not see that first.

http://ehp.niehs.nih.gov/EHP358/#tab1

BRIEF COMMUNICATION
VOLUME 124|ISSUE 7|JULY 2016

Project TENDR: Targeting Environmental Neuro-Developmental Risks. The TENDR Consensus Statement

BAM: http://www.democraticunderground.com/10141506618#post4
July 5, 2016

2011: EPA praised use of Toxics Release Inventory data by prominent autism reseacher, meanwhile...

https://www.epa.gov/sites/production/files/documents/tri_in_action_final_report_july_2013.pdf

EPA: THE ENVIRONMENTAL PROTECTION AGENCY
[CENTER]The Toxics Release Inventory (TRI) in Action: Media, Government, Business, Community and Academic Uses of TRI Data
[/CENTER]p.8

Zimmerman, J.P., Bakian A., et al. "Maternal Residential Proximity to Toxic Release Inventory Sites In Children with ASD and Other Developmental Disabilities." International Meeting for Autism Research. INSAR: International Society for Autism Research. Manchester Grand Hyatt, San Diego, CA. 12 May 2011. Lecture

http://archive.sltrib.com/story.php?ref=/sltrib/news/51759624-78/autism-utah-disorder-education.html.csp
http://archive.sltrib.com/story.php?ref=/sltrib/news/51759624-78/autism-utah-disorder-education.html.csp

Utah Autism Whistleblower Lawsuit Will Go to Trial After Federal Judge Denies a Majority of Defendants’ Motions to Dismiss
Mark Blaxill
July 5, 2016


...a Federal District Court Judge for the District of Utah issued a ruling Friday that effectively guarantees a Utah autism whistleblower her day in court. Judge Jill N. Parrish denied a majority of motions by Dr. William McMahon of the University of Utah to dismiss allegations by Dr. Judith Pinborough Zimmerman that McMahon and his colleagues acted improperly in retaliating against her for raising concerns over their research misconduct, violated university policies by terminating her contract without proper review, and impugned her reputation in the process.

<>

Dr. Zimmerman filed her lawsuit against Dr. McMahon nearly two years ago, in a complaint that describes a heated dispute between the two scientists over the proper handling of confidential health and education records as well as the accuracy of the data records used in measuring Utah’s autism prevalence as part of the Center for Disease Control’s (CDC) autism surveillance project, the Autism and Development Disabilities (ADDM) Network. Since 2002, Zimmerman had been the Director of Utah’s ADDM Network site, the Utah Registry of Autism and Developmental Disabilities (URADD). She joined the University of Utah in 2005, bringing the URADD grant with her. She was removed from her URADD and university positions in 2013.

Zimmerman’s lawsuit alleges that McMahon and colleagues violated federal records privacy restrictions in efforts to carry out lucrative additional research projects; these were privacy restrictions that she had carefully negotiated with the Utah Departments of Health and Education in order to bring URADD into compliance with federal law and protect autism families from unwanted use of their personal and family information. When Zimmerman expressed her concerns over privacy and data quality issues to University authorities, McMahon summarily fired her, locked her out of her office and placed himself in charge of URADD. Since Zimmerman’s dismissal, McMahon has become the PI of the URADD and watches over Utah’s contributions to the CDC’s ADDM reports.

<>

Zimmerman’s conflict with McMahon may have deeper roots than the privacy and data integrity claims cited in Zimmerman’s lawsuit. McMahon has been an active contributor to genetic studies of autism causation and participated as a co-author in dozens of such publications. Zimmerman, by contrast, led a study investigating “Maternal Residential Proximity to Toxic Release Inventory Sites” in children with autism. After speaking to a reporter at the Salt Lake Tribune about the study, she was reprimanded by McMahon. CDC has long been reluctant to investigate environmental causes of autism and McMahon’s interest in genetic research may well have made it easier for him to replace Zimmerman as the CDC’s Utah PI.

With a date as of yet undetermined, Zimmerman will have a chance to defend her career and reputation in front of a jury. Judge Parrish’s decision directly denied McMahon and the University’s request to dismiss Zimmerman’s allegations in 7 out of 12 causes of action in her complaint. McMahon and the University succeeded in dismissing 3 of the 12 causes; the remaining two were certified to the Utah Supreme Court, with Parrish asking for guidance in the absence of “controlling Utah law.’

No MSM coverage I can find yet.
July 4, 2016

No, I am not "being quite disgusting." It is regrettable that you or anyone might feel that way.

And it totally misses the point, unless that's the point?

ASIDE: Incidentally, my training as a dentist occurred in an era when autism was considered 1:10,000 and during my post-doc training as a pediatric dentist when I was awarded the Fellowship for Special Needs Dentistry for Children, the focus then was on treatment of children with cerebral palsy, intellectual disability, Hep B/HIV, special medical conditions (cancer, hereditary syndromes, other). Was autism even mentioned in my 2-year pediatric dentistry program? NO, it was not. Am I "being quite disgusting" to contribute on this topic with my background? NO, IMO, NOT AT ALL.
July 4, 2016

Hardly, although you said that about me on a thread yesterday and on another the day before that.

I'm with THEM, basically, among many others I could name:

http://pediatrics.aappublications.org/content/early/2016/03/17/peds.2015-4230

Pediatrics
March 2016, VOLUME 137 / ISSUE 3

Childhood Vaccine Exemption Policy: The Case for a Less Restrictive Alternative
Douglas J. Opel, Matthew P. Kronman, Douglas S. Diekema, Edgar K. Marcuse, Jeffrey S. Duchin, Eric Kodish


Abbreviations: MV — measles vaccine, NME — nonmedical exemption, VPD — vaccine-preventable disease

Efforts to restrict parents’ ability to exempt children from receiving vaccinations required for school entry have recently reached a pinnacle. The American Medical Association voiced support for eliminating nonmedical exemptions (NMEs) from school vaccine requirements,1 and California enacted legislation doing so.2 Although laudable in their objective, policies eliminating NMEs from all vaccines are scientifically and ethically problematic. In the present article, we argue for an exemption policy that eliminates NMEs just for the measles vaccine (MV) and is pursued only after other less restrictive approaches have been implemented and deemed unsuccessful.

Published By American Academy of Pediatrics
Copyright © 2016 by the American Academy of Pediatrics

Author Information: Douglas J. Opel, MD, MPHa,b, Matthew P. Kronman, MD, MSCEb, Douglas S. Diekema, MD, MPHa,b,c, Edgar K. Marcuse, MD, MPHb, Jeffrey S. Duchin, MDd,e,f, and Eric Kodish, MDg

aTreuman Katz Center for Pediatric Bioethics, Seattle Children’s Research Institute, and
bDepartments of Pediatrics and
dMedicine, University of Washington School of Medicine, Seattle, Washington;
cDepartments of Health Services and
eEpidemiology, University of Washington School of Public Health, Seattle, Washington;
fCommunicable Disease Epidemiology and Immunization Section, Public Health–Seattle and King County, Seattle, Washington; and
gDepartment of Bioethics, Center for Ethics, Humanities and Spiritual Care, Cleveland Clinic, Cleveland, Ohio

Dr Opel conceptualized and designed the study and drafted the initial manuscript; and Drs Kronman, Diekema, Marcuse, Duchin, and Kodish reviewed and revised the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

OFF-TOPIC, incidentally.

Profile Information

Member since: Wed Feb 10, 2010, 01:12 PM
Number of posts: 4,959
Latest Discussions»proverbialwisdom's Journal